MBX Biosciences

MBX Biosciences is a preclinical-stage biotechnology company dedicated to providing therapies to treat rare endocrine diseases that are underserved by available treatment options. The leadership team at MBX has successfully collaborated for decades to discover, develop, and commercialize first-in-class endocrine therapies. MBX’s standout advantage lies in its world-class patented peptide drug discovery.